SK unit builds AI-powered drug development platform
MONDAY, OCTOBER 15, 2018
SK Biopharmaceuticals, the new drug development unit of South Korea’s telecom-to-energy conglomerate SK Group, said it has finished developing an artificially intelligent drug development and design platform that is expected to speed up its new drug discovery efforts.
SK Group donates US$10 million for Attapeu flood relief
TUESDAY, AUGUST 21, 2018
The SK Group has donated US$10 million (about KRW 11.2 billion) to the Lao government as a contribution to the relief fund for the flood recovery effort in Sanamxay district, Attapeu province.